DW4421

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Clinical TrialInteraction

136 competitors in Clinical Trial

#DrugCompanyPhaseTrials

1

Gemzar

Johnson & Johnson

Phase 3

32

Venclexta

AbbVie

Phase 3

23

Avelox

Bayer

Phase 3

24

Paraplatin

AAvyxa

Phase 3

25

Potassium Iodide

MMeda Pharmaceuticals

Phase 3

16

Opzelura

DDizal Pharmaceuticals

Phase 3

17

Ablysinol

CSL Behring

Phase 3

18

Nascobal

GGrupo Espanol de Tumores Neuroendocrinos

Phase 3

19

FOLFOXIRI

SSun Yat-sen University

Phase 3

110

Glucocorticoids

Novartis

Phase 2

1Show 24 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Clinical Trial2 trials

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Recruiting·Daewon Pharmaceutical Co., Ltd.·Phase 1·NCT07343245·150 enrolled

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Enrolling by invitation·Daewon Pharmaceutical Co., Ltd.·Phase 1·NCT07364877·38 enrolled

Adult1 trial

Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers

Completed·Daewon Pharmaceutical Co., Ltd.·Phase 1·NCT07364838·24 enrolled

Interaction1 trial

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Not yet recruiting·Daewon Pharmaceutical Co., Ltd.·Phase 1·NCT07382661·36 enrolled

Details

Drug Info

Related News